T he regulatory actions ofT lymphocytes are largely mediated by the production of a group of potent polypeptides designated lymphokines (1) . Among these molecules, IL4 has been demonstrated to play an important role in the growth and development of B lymphocytes (2) and in the control of the process through which such cells switch to the secretion of IgG1 (3) and IgE (4, 5) . Long-term lines of murine CD4+ T cells have been divided into those that produce 114 but not IL-2 or IFN-y (Th2 cells) (6) , and those that produce IL-2 and IFN-T (Thl cells) . Based on their distinctive production of lymphokines, it would be anticipated that Th2 cells would be efficient helpers for antibody responses, while Thl cells should preferentially favor cellular immune response . Indeed, in experimentally infected mice in which progressive Leishmaniasis develops, antigen-specific T cell clones producing 11,4 predominate, whereas in mice that limit such infections, IL2-producing clones are mainly found (7, 8) . These results strongly suggest that the decision as to which lymphokines are produced is critical to the quality and protective value of an immune response.
Little is known regarding the factors that determine whether a given form of immunization will lead to cells that principally produce IL2 or IL4. Indeed, in naive mice, very modest amounts of IL-4 are produced by T cells in response to anti-CD3 antibodies or to mitogenic lectins (9-11) . Furthermore, the T cells in naive animals capable of producing IL4 in response to such stimulation are largely found in the low density population, suggesting that they represent cells that have already been stimulated as a result of environmental immunization (11). By contrast, IL-2 is produced by both small and large T cells, implying that the control of production of the two prototypic lymphokines may be quite different .
Furthermore, production of IL-4 by T cells from naive donors is dependent upon the presence of IL-2 (11) .
Here, we examine the increase of IL4-producing capacity among T cells in mice injected with antibodies to IgD, an in vivo polyclonal activation stimulus known to lead to the production of large amounts of IgG1 and IgE (12), Ig isotypes whose production depends upon the presence of IL-4 (3) (4) (5) 13) . We show that in such animals there is a striking increase in T cells capable of producing 11,4 in response to anti-CD3, and that this increase is first detected at about day 4, the last day on which injection of anti-IL4 antibodies can block IgE responses in such mice (14) . These results suggest that induction of IL4-producing cells is critical to IgE production in vivo and further support the concept that the regulation of lymphokine production by T cells has striking biological effects.
We also examine in vitro conditions required for high density (small) T cells, which are very poor IL-4-producing cells, to develop into cells that can be stimulated to produce this lymphokine . Swain et al. (9) have reported that acquisition of IL4-producing capacity does occur in cultures of stimulated mouse T cells, and were the first to suggest that primed but not resting T cells can produce IL4. We demonstrate here that 11,4-producing cells can be derived in vitro, in 2-3 d, from small T cells by stimulation with anti-CD3 in the presence ofboth IL-2 and IL4. Neither lymphokine alone will act as a cofactor with anti-CD3 for induction of cells capable of producing IL4 . This induction appears to be highly efficient, leading to an -100-fold increase in IL4-producing capacity. The presence of IFN-'y during this induction period does not block generation of IL-4-producing T cells, a somewhat surprising result in view of the effect of IFN-y in preventing the outgrowth of IL4-producing T cell clones in vitro in response to stimulation with antigen and IL2 (15) .
Materials and Methods
Animals. Virus-free BALB/c female mice, 8-12 wk of age, were obtained from Division of Cancer Therapy Animal Program, National Cancer Institute, Bethesda, MD.
Culture Medium. RPMI 1640 (Biofluids, Rockville, MD) supplemented with 10% FCS (HyClone Laboratories, Logan, UT), L-glutamine (2 mM), sodium pyruvate (1 mM), 2-ME (0.05 mM), Hepes (10 mM), penicillin (100 U/ml), and streptomycin (100 P, g/ml) was used for culturing cells.
Preparation of T Cells. Cell suspensions were prepared from lymph nodes ofuntreated mice or mice that had been injected with 800 wg of anti-IgD 5 d earlier. The cells were washed two times in HBSS and suspended at 4°C for 1 h with a mixture of fluorescence (Fl)'-conjugated antibodies containing 10 Rg/ml of anti-B220 (6B2) and anti-lad (MKD6) . At the end of the incubation, the cells were washed twice in staining buffer and mixed for 1 h at 4°C with a suspension of magnetic beads coated with sheep anti-Fl antibodies (Advanced Magnetics Inc., Cambridge, MA) (12 ml/108 stained cells). Positively staining cells were depleted by two 20-min cycles ofexposure to a magnetic field. The remaining cells were washed twice in culture medium and examined for the removal of the B cells by cytometric analysis on a FACScan (Becton ' Abbreviation used in this paper. Fl, fluorescence.
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Dickinson & Co., Mountain View, CA). In general, residual B cell content was <1%.
Fractionation of Large and Small T Cells. T cells from lymph nodes were layered onto a discontinuous Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden) gradient (70, 66, 60, and 50% Percoll) and centrifuged at 1,000 g for 20 min at room temperature . The cells at the interface between 50 and 60% Percoll (large), 60 and 66% (medium), and 66 and 70% (small) werecollected, washed twice with HBSS, and resuspended in culture medium.
Lymphokines and Cytokines. Human rIIr2 was a gift of Cetus Corp. (Emeryville, CA). 9,2 activity was defined in terms of"Cetus Units". 1 Cetus U is is equivalent to -0.3 ng and to 6 WHO IU. Synthetic IL3 was a gift o£ Dr. Ian Clark-Lewis (Biomedical Research Center, Vancouver, Canada) . 1 U of IIr3 was defined as the amount of IL3 that stimulated half-maximal ['H]thymidine incorporation by FD.C/1 cells. Mouse rlIr4 was obtained from a baculovirus expression system, utilizing a vector into which the 114 gene had been inserted by C. Watson, Laboratory of Immunology, MAID, Bethesda, MD. 114 activity was measured using the CT4S cell line (16) , comparing it with a standard that had initially been calibrated on the basis of 10 U/ml being equal to the amount of 114 required for half-maximal stimulation of ['H]thymidine uptake by resting B cells stimulated with 5 ug/ml ofgoat anti-IgM antibody (2, 17) . 1 U is equal to -0.5 pg of protein. Mouse rIFN-y was a gift of Genentech, Inc., South San Francisco, CA. Mouse rID5 was expressed in a baculovirus system, utilizing a vector into which the IL5 gene had been inserted by C. Watson, D. Kunimoto, and G. Harriman, MAID.
Igs and mAbs. The following antibodies were prepared by a combination ofammonium sulfate precipitation, DE52 ion exchange chromatography, and Sephadex G200 gel filtration (18) ; anti-IL2 (S4 .B6) (19) ; anti-CD3 (2C11) (20) ; anti-B220 (6B2) (21); and antiIad (MKD6) (22) . Purified Ig was fluoresceinated with FITC, as previously described (23) . Purified monoclonal rat anti-mouse IL4 (11B11) (24) was prepared by Verax Corporation (Hanover, NH) . Affinity-purified goat anti-mouse IgD antibody was prepared as previously described (18) .
Measurement ofLymphokine Productionfrom Cells Stimulated by PlateBound Antibodies. Flat-bottomed 96-well microtiter Immulon 2 plates (Dynatech Laboratories, Inc ., Alexandria, VA) were coated by incubation for 4 h at room temperature with purified anti-CD3 antibody (2C11 ; 10 wg/ml in 50 w1 borate buffered saline, pH 8.5). Wells were washed three times with 200,ul HBSS. Cells were added to the antibody-coated wells (in triplicate) in 0.2 ml culture medium . After 36 h in culture, the plates were exposed to 1000 rad in an irradiator (Gamma Cell 40; Atomic Energy of Canada Ltd., Ontario, Canada) . Lymphokine-dependent lines (CT EV [16] , an IIr2-dependent line, or CT4S, an 11,4-dependent line) were then added (5,000 cells/well) to measure the secretion of the individual lymphokines (11, 25) . 48 h later, 1 pCi of ['H]thymidine (ICN, Irvine, CA) was added, and after 10 h the cells were harvested . Incorporation of tritium was measured in a liquid scintillation spectrometer. Relative SEs for triplicates had a mean value of 15% or less. The amount oflymphokine was expressed as either the quantity of ['H]thymidine incorporated into the DNA of the indicator cell line or as the equivalent of the amount of lymphokine required to support the same level of thymidine incorporation in the indicator cell line (equivalent units) .
IL content of the supernatant of activated cells was assessed by adding 5,000 cells from each of the appropriate cell lines to supernatant of one well (CTEV for IL-2; CT4S for 11,4; FD.C/1 [26, 27] , an 11,3-dependent line, for IL3). The extent of IL secretion was determined by incorporation of ['H]thymidine as described earlier in this section. IFN-y was assayed by its ability to inhibit plaque formation by vesicular stomatitus virus on L929/2G1 cells. The level of 11,5 in the supernatants was determined by an ELISA with two anti-IIL5 mAbs (28) . We thank Dr. Robert Coffman (DNAX Institute of Molecular and Cell Biology, Palo Alto, CA) for making these measurements .
Generation offI,4producing T Cells In Vitra Small T cells from lymph nodes of naive mice were incubated on anti-CD3-coated tissue culture dishes (2-3 x 10 5 cells/5-cm dish) in 3 ml culture medium alone or in culture medium supplemented with lymphokines and/or antilymphokine antibodies as specified in the legends. After 3 d in culture, 2 ml of fresh culture medium and the appropriate lymphokines and/or antilymphokine antibodies were added. 2 d later, the cells were collected, washed three times with HBSS, and resuspended in culture medium to further test their IL4-producing capability on anti-CD3-coated wells. In such experiments, a series of concentrations of live cells were tested for IL-4-producing capacity. Comparisons between groups therefore represent comparisons of IL4-producing capacity by specified numbers of living cells.
Results

T Cells from Mice Injected with Anti-IgD Antibody Produce
More 11,4 than T Cellsfrom Naive Mice. T cells from naive mice produce small amounts of 11,4 in response to stimulation with anti-CD3 coated on the surface of culture wells. Polyclonal stimulation by injection ofanti-IgD causes striking increases in serum IgE in 7-8 d that can be inhibited by treatment of these mice with anti-IL-4 antibody, administered as late as 4 d after injection of anti-IgD (14) . These results indicate that 11,4 is critical to the elevation of serum IgE that occurs in these mice and suggest that induction of IL-4-producing capacity occurs in such animals. We have previously shown that freshly isolated T cells from anti-IgD-injected mice secrete small amounts of 114 without in vitro stimulation (29) . To determine whether this polyclonal stimulation resulted in an increase in the capacity of mice to produce IL-4 in response to anti-CD3 coated on culture dishes, lymph node T cells were prepared from mice that had not been injected with anti-IgD and from mice injected 2, 4, 6, 8, and 11 d earlier with 800 Ag of anti-IgD. Since we have shown that the capacity of T cells from naive donors to produce IL4 in response to anti-CD3 requires the presence of IL-2 (11), human 1172 (50 U/ml) was added to all cultures, Fig. 1 A shows a striking increase in IL-4-producing capacity oflymph node T cells from anti-IgD-injected donors that peaks between 4 and 6 d after injection. In Fig. 1 B, the IL4-producing capacity of T cells from naive donors and from donors injected with anti-IgD 5 d earlier is compared in detail . 5,000 T cells from anti-IgD-injected mice produce more IL4 in response to anti-CD3 plus IL2 than 100,000 T cells from naive donors, indicating that the polyclonal activation known to lead to IgE production is marked by a striking increase in the IL4 producing capacity of the lymph node T cell population .
71,4 producing T Cellsfrom Primed Donors Have Low and In-
termediate Densities. High density T cells from naive donors produce very little IL4 in response to anti-CD3 and 11,2, even in the presence of exogenous accessory cells . The 11,4-producing cells from these mice are markedly enriched in the low density T cell population (11). Similarly, IL4-producing T cells from anti-IgD-injected donors are concentrated in cells oflow and intermediate density (Fig. 2) . Purified T cells were Figure 1 . Anti-IgD injection causes an increase in T cell production of IIJ4 in response to anti-CD3. (A) T cells were prepared from mice that had been injected with 800 tcg of anti-IgD 2, 4, 6, 8, and 11 d earlier and from mice that had not been injected with anti-IgD (day 0). Cells were cultured, in the presence of 11,2 (50 U/ml), at 5,000/well on culture plates that had been coated with anti-CD3 . Cultures were irradiated (1,000 rad) at 36 h, and 5,000 CT4S cells were added. After 48 h, [3I-11thymidine was added, and incorporation into DNA was measured 10 h later as an index of IL4 production. Figure 3 . Neutralization of 11,2 diminishes 11,4 production by T cells from mice injected with anti-IgD. T cells were prepared from mice that had been injected with anti-IgD 5 d earlier and cultured on wells that had been coated with anti-CD3 . IL-2 (50 U/ml), anti-mouse 11,2 (S4.B6 [10 14g/ml]), anti-mouse 1162 plus a 1:100 dilution of a mixture of ascitic fluids of the anti-11,2R mAbs 3C7, 7134, 2E4, and PC61, or nothing was added to wells . 11,4 production was measured as described in Fig. 1 , except that the results are expressed as "equivalent units" rather than as uptake of [ 3H]thymidine.
Equivalent units represents the amount of IL-4 added to CT4S cells that gives [3H]thymidine uptake equivalent to that observed in the CT4S coculture assay. Since 11,2 at 50 U/ml, but not at lower concentrations, enhances responses of CT4S cells to ILA the doseresponse curve that was used to calculate equivalent units for the group to which IL-2 had been added was derived from responses of CT 4S cells to which 114 had been added in the presence of 50 U/ml of 11,2, while the dose-response curve used to calculate equivalent units for the other groups was derived from responses of CT4S cells to which IL4 was added in the absence of 11,2 .
fractionated by Percoll density gradient centrifugation into low density (50-60% Percoll), intermediate density (60-66%), and high density (>66%) populations. High density cells produced very little IL4 in response to anti-CD3 in comparison with low and intermediate density cells (Fig. 2) . In these experiments, IL-2 was added to all cultures to maximize ILA production. These results indicate that among T cells from recently stimulated mice, just as was true of T cells from naive donors, the major IL4-producing cell population is made up ofcells of low and intermediate density. Since resting cells are found mainly in the high density population, it would appear that the small resting T cell population in polyclonally activated as well as in naive donors has very limited capacity to produce ILA in response to anti-CD3.
IL4 Production by T Cells From Anti-IgD-injected Mice Is Inhibited by Neutralization ofIL2. IL4 production by T cells from naive donors cultured on anti-C133-coated plates is enhanced by the addition of 11,2 and completely inhibited by the addition of the monoclonal anti-mouse IL-2 antibody S4.B6 (11). The latter result indicates that in situ production of IL2 is normally required for IL4 production by cells from naive donors stimulated with anti-CD3. To examine whether T cells that had been "activated" in vivo as a result of injection of anti-IgD also required 11,2 in order to produce IL4, lymph node T cells from such donors were cultured, in varying numbers, in wells coated with anti-CD3. These cells produced substantial amounts of 11,4 (Fig. 3) . In this experiment, the results are reported in terms of "IL-4 equivalent units" rather than [3H]thymidine uptake by CT4S cells, since IL-2, at 50 U/ml or more, increases the response ofCT4S cells to ILA (16) . IL4 equivalent units were calculated from dose-response curves carried out in the presence or absence of exogenous human rIL2 (50 U/ml), as appropriate.
IL-4 production by T cells from anti-IgD-injected donors, cultured on anti-CD3-coated wells, is substantially enhanced by the addition ofhuman IL2 . On the other hand, the addition of the monoclonal anti-mouse IL-2 antibody S4.136, at 10,ug/ml, significantly, but incompletely, inhibits IL4 production by T cells cultured in anti-CD3-coated wells in the absence of exogenous IL-2. This degree of inhibition was only slightly increased by using a mixture of anti-IL2 with four independent antibodies to the p55 chain of the IL-2R (7134, 3C7, 2E4, and PC61) (Fig. 3) . These results indicate that a major component of IL-4 production by T cells from "recently activated" donors is dependent upon the presence of IL-2. This is particularly striking when one compares IL-4 production in the presence of exogenous 11,2, to maximize ILA production, with that in the presence of antibodies that neutralize endogenous 11,2. 5,000 of the former cells produce more IL4 than 40,000 of the latter. Whether the residual production ofIL-4 in the presence of anti-IL-2 and antip55 represents an IL-2-independent response or is due to the difficulty of fully blocking the action of endogenously produced IL-2 is not clear.
High Density T Cells from Naive Donors Contain Precursors that Can Be Stimulated to Develop into RA-producing Cells. The ability of T cells from primed donors to produce substantially more IL4 than T cells from naive animals in response to anti-CD3 plus IL2 suggests that the unprimed cell population contains cells that, under appropriate in vivo conditions, give rise to expanded numbers of IL4-producing cells. Since high density T cells from naive and anti-IgD-injected mice have very little capacity to produce IL4, the development of IL4-producing cells from this population would be particularly striking . Thus, we sought in vitro conditions that would allow the appearance of IL4-producing cells from the high density T cell population of naive donors. We observed that culturing these cells for 5 d on anti-CD3-coated dishes together with IL-2 and IL4 led to the appearance of a cell population that produced large amounts of IL-4 in response to anti-CD3 plus IL-2 (Fig. 4) . Thus, we observed that 312 cells primed in vitro produced more IL-4 than did 20,000 high density cells from naive donors. This in vitro primed T cell population was the richest source ofILA production that we have observed, exceeding that of T cells from anti-IgD-injected donors .
Both 11,2 and IL4 were essential for the appearance of cells that could produce ILA in response to restimulation with anti-CD3 plus 11,2. A priming culture of high density T cells from naive donors with anti-CD3 plus IL-2 and monoclonal anti-114, to neutralize any IIJ4 that was produced endogenously, did not result in the emergence of cells that could produce IL-4 in response to anti-CD3 plus IL2 (Fig. 5 A) . Similarly, cells cultured with anti-CD3 plus IL-4 and anti- Figure 4 . In vitro culture of dense T cells with anti-CD3 plus IL2 and 11,4 causes a striking increase in I1,4-producing capacity. T cells from naive donors were separated by Fercoll density gradient centrifugation . The dense cells (2 x 105) were cultured in a 5-cm dish that had been coated with anti-CD3, in the presence of 3 ml of culture medium containing IL-2 (50 U/ml) and 11,4 (1,000 U/ml). After 3 d of culture, 2 ml of lymphokine-containing medium was added. At 5 d, the cells were harvested and transferred to 96-well culture plates that had been coated with anti-CD3 and cultured in the presence of IL2. 11,4 production was measured as described in Fig. 1 . Dense T cells from naive mice were freshly prepared and cultured in 96-well plates coated with anti-CD3 at the same time as the cells that had been cultured for 5 d were harvested and recultured .
11,2 antibody also failed to produce IL4 in the secondary culture. If the monoclonal anti-IL4 antibody was not included in the group cultured with anti-CD3 plus IL2, little or no IL4 was produced in the second culture, presumably because high density T cells produce very little IL4 in response to anti-CD3 plus IL2 in the primary culture. By contrast, if anti-IA was not added to cells cultured with anti-CD3 plus IL4, this cell population did give rise to IL4-producing T cells (data not shown) . This is consistent with the capacity of high density T cells to produce IL2 in response to culture with anti-CD3 and, as shown in Fig. 6 A, with the finding that relatively small amounts of exogenous IL2 in primary cultures with anti-CD3 and ILA are sufficient to permit the appearance of IA-producing cells . Anti-CD3 was essential during the first culture . Cells cultured in IL2 plus IL4, or in IL2 or IL-4 alone, failed to produce 1164 upon secondary culture with anti-CD3 plus IL2 (Fig. 5 B) . The requirement of anti-CD3 plus IL2 and IL4 could not be explained by improved cell yields, as the number ofliving cells were essentially the same in groups cultured with anti-CD3 plus IL2 or IL4 as they were in the group cultured with anti-CD3 plus IL2 and IL4 (data not shown) . In addition, IL4-producing capacity is expressed in terms of IL4 produced per number ofviable cells cultured in the secondary culture.
In the secondary culture, the IL4-producing cells showed requirements for stimulation of lymphokine production similar to that of T cells from both naive and anti-IgD-injected donors. Anti-CD3 alone did elicit IL-4 production, but the addition of exogenous IL2 markedly enhanced 11,4 production ( Fig.  5 C) . In other experiments (data not shown), monoclonal anti-IL2 antibody diminished the production of IL4 in response to anti-CD3 alone, indicating that the in vitro primed cells retain a substantial dependence on IL-2 for IL4 production .
Relatively small amounts of IL-2 are required during the priming culture with anti-CD3 and IIA Thus, in the presence of anti-CD3 and 1,000 U/ml of IL4, 0.4 U/ml (120 pg/ml) of human IL2 gave a definite induction of cells capable of producing IL4 upon subsequent culture with anti-CD3 and IL2 (Fig. 6 A) . In these experiments, endogenously produced murine IL-2 was neutralized with the monoclonal anti-mouse 1172 antibody AM. In the presence of 50 U/ml of human IL-2, 100 U/ml of IL-4 (ti50 pg/ml) has some inducing activity, but there is a dose-dependent increase with 1,000 U/ml being much more effective.
Requirements for Induction of IIr4producing Cells. Our experiments thus far have all utilized a protocol in which dense T cells from lymph nodes of naive donors are cultured on plates coated with anti-CD3 plus IL-2 and IL-4 for a period of 5 d, and are then removed from these plates and restimulated with anti-CD3 plus IL2. We examined two additional aspects of this process: the time required for this induction and the capacity of IFN-y to inhibit it. Fig. 7 presents two experiments in which cells were cultured with anti-CD3, 1172, and IIA for periods of <5 d. Exp. A compares 3 d ofpriming with 5 d. In that experiment, the cells harvested at the end of a 3-d priming culture are quite similar to cells harvested at 5 d in their capacity to produce IIA and are considerably superior to the cells that had been tested without such preculture (day 0 cells) or to cells cultured without IL2 or 114 (data not shown) . Exp . B shows that induction of IL-4-producing cells can also be achieved within 2 d, indicating that the process of inducing IL4-producing cells from a resting Figure 7 . Anti-CD3 plus 11,2 and 11,4 increase 1164-producing capacity of T cells within 2 d . Dense T cells from naive donors were cultured in 5-ml culture dishes coated with anti-CD3 in the presence of 11,2 (50 U/ml) and 11,4 (1,000 U/ml) for 3 or 5 d (Exp. A) or 2 or 3 d (Exp. B) . At the end of the initial culture period, the cells were harvested and transferred to 96-well plates that had been sensitized with anti-CD3 . Secondary cultures were carried out in the presence of 11,2. Results are expressed as equivalent units, since secondary assays were not carried out at the same 105 time . Dose-response curves used for calcula-CELLSIWELL tion of equivalent units were performed in parallel with the CT 4S coculture assay. DAY 0 T cell population is a relatively rapid one if the stimulatory conditions are correct .
IFN-y has been reported to inhibit the growth of clones of T cells that produce IL4 in response to stimulation with antigen, APC, and IIA (15) . To test the effect of IFN-y during the in vitro priming of lymph node T cells with anti-CD3 plus IL2 and IL4, we added IFN-y to these cultures and compared the IL4 producing capacity of the cells that were obtained. Fig . 8 A shows that 100 U/ml of IFN-y added to the priming culture has little or no effect on the appearance of cells that can produce IIA in response to subsequent culture with anti-CD3 plus 11,2. 500 U/ml has a modest inhibitory activity. Furthermore, addition of IFN-y (250 U/ml) during the elicitation phase of the culture also failed to prevent IIA production (Fig. 8 B) . These results indicate that IFN-y does not have a profound effect on the appearance of IL4-producing cells in the anti-CD3 plus IL2 and IL4 system described here.
Discussion
T cells from naive donors stimulated with anti-CD3 adsorbed onto culture wells produce little IL4. In the presence of IL-2, IL4 production is substantially enhanced, but this production is found mainly in cells of low and intermediate density. High density cells, which contain small resting T cells, produce very little IL4, even in the presence of IL2 and with supplementation by accessory cell populations (11). Swain et al. (9) had previously reported that resting normal T cells were poor IL4-producers. They had concluded that IL4-producing capacity was a property of primed T cells.
The poor IL4-producing capacity of dense T cells from naive donor stimulated with anti-CD3 are somewhat at odds with a recent report by Carding et al. a limiting dilution assay to enumerate IL4-producing cells (Seder et al., manuscript in preparation) . Using this approach, we find that the frequency of T cells from lymph nodes of naive donors that produce IL4 in response to anti-CD3 plus IL2 is N1:1000. It should also be pointed out that studies of recently primed mice have shown that among antigenprimed T cells, IL4 producers are rare, although they increase in number upon repetitive stimulation in vitro (10).
In this manuscript, we demonstrate that in vivo polyclonal activation of mice by injection of anti-IgD antibodies strikingly increases the capacity of lymph node T cells to produce IL4 in response to anti-CD3 plus IL2. This is in keeping with the increase in serum IgE levels in such animals (12) and with the demonstration that treatment of these mice with mAbs to IL4 (13) or to the IL4R (32) completely inhibits this increase. Indeed, we have previously shown that anti-IL4 antibody treatment is effective in inhibiting the IgE response to anti-IgD when administered as late as the fourth (but not fifth) day after injection (14) . The observation that increased IL4 production by T cells from anti-IgD-injected donors is first observed on day 4 is consistent with the time course of sensitivity to anti-IL 4. It indicates that the control of induction of IL4-producing capacity is critical to the increase in IgE that occurs in certain forms ofimmunization . We have also observed that infection with Nippostrongylus brasiliensis, which causes a striking increase in serum IgE, causes a similar increase in T cell production of IL4 (Le Gros et al., unpublished observations) .
IL4 production by T cells from anti-IgD-injected donors has many features in common with IL4 production by T cells from naive donors. It is mainly a property of low and intermediate density T cells, and IL2 plays a very important role in IL4 production. When anti-CD3-treated T cells from naive donors are treated with monoclonal anti-IL2 antibody (S4.B6), IL4 production is not detectable (11). Treatment of T cells from anti-IgD-injected donors with S4.B6 causes a marked inhibition of IL4 production, particularly when one compares IL4 production in anti-CD3-treated cells that have received exogenous IL2 with anti-CD3-treated cells to which anti-IL2 has been added. Nonetheless, a portion of the IL4 response by T cells from anti-IgD-primed donors is not inhibited by anti-IL2. This may reflect an IL2-independent component of IL4 production that develops with time after priming. Indeed, the fact that T cell lines of the Th2 type produce IL4 in response to anti-CD3, mitogens or antigens in the absence of exogenous IL2 strongly suggests that certain cells can produce IL4 without the need for IL2 (33) .
Although dense T cells from naive donors have very limited capacity to produce IL4 in response to anti-CD3 plus IL2, they contain cells that develop into IL4 producers. Indeed, Swain et al. This system provides an in vitro approach for the study of the events that regulate development of cells into IL4 producers. One obvious question is whether stimulation with anti-CD3 plus IL2 and IL4 causes "uncommitted" cells to differentiate into cells that can produce IL4, or whether it causes the proliferation of cells already capable of producing IL4 in response to anti-CD3 plus IL2. Although the evidence available is not decisive, we favor the idea that cells that can produce IL4 in response to anti-CD3 plus IL2 in the dense T cell population from naive donors are not the precursors (or the sole precursors) of the cells that produce IL4 that appear after culture with anti-CD3 plus IL2 and IL4. Our major reason for this is that the IL4-producing capacity of the dense T cell population from naive donors is very meager and, as our unpublished work has shown, IL 4-producing cells are very rare. Thus, these cells would have to proliferate in preference to other cell types that are being stimulated to proliferate by anti-CD3 plus lymphokines. While it is certainly possible that such proliferation could explain the appearance of IL4 producers in a 5-d period, the fact that they can be observed in as few as 2 d suggests that it is more likely that the cells have differentiated from precursors that do not, themselves, produce IL4 in response to anti-CD3 plus 11,2. Whether those cells are committed to making 114 or can differentiate in other ways can best be addressed by limiting dilution progenitor analyses .
Finally, it is important to point out that crosslinking the TCR in the presence of IL2 and 114 is unlikely to be the only means through which IL4 producing cells may be induced . This is particularly so since 114-producing cells are rare among naive T cell populations. Thus, in initial priming for a response dominated by I14-producing cells, 114 may not be available in the location or in the amounts required for the induction we have observed. We have recently shown that mast cells can produce IL4 (34, 35) , and we have reported the existence of a population of splenic and bone marrow cells, lacking B and T cell markers, that express high affinity Fce receptors and produce IL4 in response to the crosslinkage of such receptors (25) . These cells are a potential source of 114 for the priming system described here. However, IL3 is required for substantial 11,4 production in response to Fce receptor crosslinkage on non-B, nonT cells (36) . Thus, in unstimulated animals, the non-B, nonT pool is not a strong candidate for a source of IL4 for priming small T cells to develop into IL4-producing cells . Indeed, non-B, nonT cells from naive donors are relatively poor producers of IL4 when compared with non-B, nonT cells from anti-IgD-injected or Nippostrongylus brasiliensis-infected mice. Another reason to suggest that the anti-CD3 plus IL2 and 11,4 model is not the only way through which IIL4-producing cells can be induced is the finding that IFN-y blocks the appearance of IL4-producing cell lines in response to stimulation with antigen, APC, and IL2 (15) . By contrast, IFN-y does not inhibit the generation of114-producing cells in the anti-CD3 plus IL2 and 114 system, nor does it inhibit 11,4 production by such T cells in response to anti-CD3 plus IL2.
We would suggest that the induction of IL4-producing cells from precursors in response to receptor crosslinkage plus IL-2 and 1174 could be important in situations in which some IL4-producing T cells had already been induced . Based on the characteristics of T cell clones isolated from chronically infected mice (7, 8 ), it appears that responses tend to be dominated by T cells that produce IL-2 or T cells that produce 114. This "polarization" ofresponse at least in the direction of IL4-producing cells could represent a positive "feedback" regulation resulting from the presence of substantial amounts of 114 at the time that newly emerging T cells initially encounter antigen, particularly an antigen to which the immune system was chronically exposed . Indeed, it has recently been reported that treatment of Leishmania major-infected BALB/c mice with anti-I14 antibody attenuates infection in these animals and diminishes levels of 114 mRNA in lymph nodes draining sites ofinfection (37) . This suggests that IL4 may be important, in vivo, in appearance or persistence of
